Award
National Institutes of Health RFA-NS-21-005
Longitudinal validation of cerebral small vessel disease biomarkers in diverse community-based older adults without dementia
Recipient
RUSH UNIVERSITY MEDICAL CENTER
Award Amount
$1,138,042.00
Ceiling
$1,138,042.00
Awarded
July 28, 2025
Identifier
RFA-NS-21-005
NIH awarded a research project to Rush University Medical Center to validate cerebral small vessel disease biomarkers in diverse older adults without dementia, with a focus on improving diagnosis and treatment of related cognitive decline.
Description
NIH research project focused on validating biomarkers for cerebral small vessel disease in diverse populations. The project involves longitudinal clinical validation, neuroimaging, and neuropathologic indices. Led by Konstantinos Arfanakis at Rush University Medical Center, aiming to improve diagnosis, prevention, and treatment of SVD-related cognitive decline and dementia.